Bharat Biotech, Sydney University ink MoU to collaborate on vaccine R&D & infectious diseases
Bharat Biotech International Limited (BBIL), the developer of India’s first indigenous Covid-19 vaccine Covaxin, on Tuesday said it has inked a memorandum of understanding (MoU) with the University of Sydney Infectious Diseases Institute (Sydney ID) to collaborate on advancing vaccine research initiatives, strengthening academic-industry partnerships and augmenting global efforts to combat infectious diseases.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
